OOIR: Observatory of International Research

Papers

(The TQCC of Pigment Cell & Melanoma Research is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Issue Information	99
	48
	37
Circadian clock protein BMAL1 regulates melanogenesis through MITF in melanoma cells	35
Retrospective review of outcomes associated with metastatic melanoma patients treated with 1st‐line BRAF‐targeted therapy	32
Let’s talk about sex: A biological variable in immune response against melanoma	25
Cytoglobin functions as a redox regulator of melanogenesis in normal epidermal melanocytes	25
Molecular heterogeneity of quiescent melanocyte stem cells revealed by single‐cell RNA‐sequencing	25
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma	23
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)	22
Oral Melanoma in Older Adults: Epidemiology, Molecular Landscape, and Treatment Strategies	22
The Melanocyte and Nerve Fiber Cross‐Talk, Facilitated Also by Semaphorin‐4A, Enhances UV‐B‐Induced Melanogenesis	20
Issue Information	20
Issue Information	17
25th International Pigment Cell Conference, Bilbao, Spain IPCC 2023	17
Issue Information	17
Impact of a SLC24A5 variant on the retinal pigment epithelium of a Japanese patient with oculocutaneous albinism type 6	16
Modeling of pigmentation disorders associated with MITF mutation in Waardenburg syndrome revealed an impaired melanogenesis pathway in iPS‐derived melanocytes	16
Comprehensive Profiling of Acral Lentiginous Melanoma Reveals Downregulated Immune Activation Compared to Cutaneous Melanoma	14
Progress in melanoma treatment: Patient's perspectives	14
Abstracts	14
Issue Information	13
Corrigendum	13
	13
Corrigendum	13

The AMP‐dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma	12
PASPCR 2024 Annual Meeting, New York, NY	12
Issue Information	12
Sex Differences in Acral Lentiginous Melanoma: A Retrospective Cohort Analysis of 3617 Cases From the Surveillance, Epidemiology, and End Results Database	12
Single‐cell profiling of MC1R‐inhibited melanocytes	11
Neratinib kills B‐RAF V600E melanoma via ROS‐dependent autophagosome formation and death receptor signaling	11
Celebrating the life of James J. Nordlund, MD, a larger‐than‐life scholar, mentor, and friend	11
Cover Image	10
Association Between Melanoma Metastasis and Metabolic Syndrome: A Cross‐Sectional Study in a Chinese Population	10
	10
Mouse Tail‐Skin Dissociation and Preparation of Live Single‐Cell Suspension for Downstream Analysis of Melanocytes	8
MetFinder: A Tool for Automated Quantitation of Metastatic Burden in Histological Sections From Preclinical Models	8
BORIS/CTCFL‐mediated chromatin accessibility alterations promote a pro‐invasive transcriptional signature in melanoma cells	8
	7
Issue Information	7
Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023	7
	7
Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma	7
Dominant Negative Mitf Allele Impacts Melanophore and Xanthophore Development and Reveals Collaborative Interactions With Tfec in Zebrafish Chromatophore Lineages	7
Cover Image	6
The delicate relation between melanocytes and skin immunity: A game of hide and seek	6
Issue Information	6
Cover Image	6
Beyond the 5‐year milestone: Long‐term survivorship of melanoma patients treated off‐trial with anti‐PD‐1	6
Issue Information	5
Topical antibiotics limit depigmentation in a mouse model of vitiligo	5
Special issue: “Biology of skin pigmentation and pigmentary diseases”	5
Three‐dimensional imaging for the analysis of human epidermal melanocytes	5
Two novel CreER^T2 transgenic mouse lines to study melanocytic cells in vivo	5
The metabolism of melanin synthesis—From melanocytes to melanoma	5
UVA Irradiation Promotes Melanoma Cell Proliferation Mediated by OPN3 Independently of ROS Production	5
Induced pluripotent stem cells reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model	5
Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment	5
Acral lentiginous melanoma—Population, treatment, and survival using the NCDB from 2004 to 2015	5
Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1‐Associated Genes in Finnish Patients with Uveal Melanoma	5
5,6‐Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation	5
Genetic and phenotypic heterogeneity of multiple lentigines and precise diagnosis in four Chinese families with multiple lentigines	4
2‐Mercaptonicotinoyl glycine, a new potent melanogenesis inhibitor, exhibits a unique mode of action while preserving melanocyte integrity	4
ToF‐SIMS imaging reveals changes in tumor cell lipids during metastatic progression of melanoma	4
Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab	4
Cutaneous Pigment Cell Distributions and Skin Structure of Xenopus	4
Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism	4
Segregation Between an Ornamental and a Disease Driver Gene Provides Insights Into Pigment Cell Regulation	4
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants	4
TFE3 promotes ferroptosis in melanoma	4
Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era	4
Advancements in melanoma cancer metastasis models	4
The OSUMMER lines: A series of ultraviolet‐accelerated NRAS‐mutant mouse melanoma cell lines syngeneic to C57BL/6	4
Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance	4
Issue Information	4

Clinicopathological features, current status, and progress of primary central nervous system melanoma diagnosis and treatment	4
The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta‐analysis	4